Aspirin and P2Y12 inhibitors were prescribed less frequently in MINOCA when compared to MI-CAD patients (87.68% vs. 92.45%, p < 0.001; 67.58% vs. 84.80%, p < 0.001, respectively). The gene discussed is P2RY12; the disease is myocardial infarction.